{"id":"https://openalex.org/W3000307305","doi":"https://doi.org/10.1038/s41416-019-0724-y","title":"Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma","display_name":"Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma","publication_year":2020,"publication_date":"2020-01-14","ids":{"openalex":"https://openalex.org/W3000307305","doi":"https://doi.org/10.1038/s41416-019-0724-y","mag":"3000307305","pmid":"https://pubmed.ncbi.nlm.nih.gov/31932756","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7078299"},"language":"en","primary_location":{"id":"doi:10.1038/s41416-019-0724-y","doi":"https://doi.org/10.1038/s41416-019-0724-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-019-0724-y","pdf_url":"https://www.nature.com/articles/s41416-019-0724-y.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/s41416-019-0724-y.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074055360","display_name":"Manoela Tiago","orcid":"https://orcid.org/0000-0003-0536-2580","observed_orcids":["https://orcid.org/0000-0003-0536-2580"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manoela Tiago","raw_affiliation_strings":["Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008451208","display_name":"Claudia Capparelli","orcid":"https://orcid.org/0000-0001-9834-8539","observed_orcids":["https://orcid.org/0000-0001-9834-8539"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia Capparelli","raw_affiliation_strings":["Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009622329","display_name":"Dan A. Erkes","orcid":"https://orcid.org/0000-0001-6303-7191","observed_orcids":["https://orcid.org/0000-0001-6303-7191"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan A. Erkes","raw_affiliation_strings":["Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085398803","display_name":"Timothy J. Purwin","orcid":"https://orcid.org/0000-0002-7053-8039","observed_orcids":["https://orcid.org/0000-0002-7053-8039"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Purwin","raw_affiliation_strings":["Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085086811","display_name":"Shea A. Heilman","orcid":"https://orcid.org/0000-0003-4337-5446","observed_orcids":["https://orcid.org/0000-0003-4337-5446"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shea A. Heilman","raw_affiliation_strings":["Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021531753","display_name":"Adam C. Berger","orcid":"https://orcid.org/0000-0003-1192-3276","observed_orcids":["https://orcid.org/0000-0003-1192-3276"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam C. Berger","raw_affiliation_strings":["Department of Surgery, Thomas Jefferson University, Philadelphia, PA, 19107, USA","Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Thomas Jefferson University, Philadelphia, PA, 19107, USA","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":["Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062746446","display_name":"Andrew E. Aplin","orcid":"https://orcid.org/0000-0002-2734-3244","observed_orcids":["https://orcid.org/0000-0002-2734-3244"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew E. Aplin","raw_affiliation_strings":["Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA. Andrew.Aplin@jefferson.edu","Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA. Andrew.Aplin@jefferson.edu","Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA. Andrew.Aplin@jefferson.edu","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA. Andrew.Aplin@jefferson.edu","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]},{"raw_affiliation_string":"Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5062746446"],"corresponding_institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":{"value":3300,"currency":"USD","value_usd":3300},"fwci":0.9724,"has_fulltext":true,"cited_by_count":28,"citation_normalized_percentile":{"value":0.70885419,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"122","issue":"6","first_page":"789","last_page":"800"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bet-proteins","display_name":"BET proteins","score":0.6060000061988831},{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.9399999976158142},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9399999976158142},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":1.0},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.9440000057220459},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pdgfrbeta","display_name":"PDGFR\u03b2","score":0.9509999752044678},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.8880000114440918},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6570000052452087},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6493111252784729},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.6471456289291382},{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.6264480352401733},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.623985230922699},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6147633194923401},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5836150050163269},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4944489002227783},{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.47401362657546997},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.47086775302886963},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4640248417854309},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.4446994662284851},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.43685290217399597},{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.43010246753692627},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.3538338840007782},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.32899773120880127},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21337813138961792},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21326467394828796},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19065585732460022},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1906318962574005},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17262059450149536},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/s41416-019-0724-y","doi":"https://doi.org/10.1038/s41416-019-0724-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-019-0724-y","pdf_url":"https://www.nature.com/articles/s41416-019-0724-y.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6710836","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC7078299","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7078299","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7078299","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:31932756","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31932756","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41416-019-0724-y","doi":"https://doi.org/10.1038/s41416-019-0724-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-019-0724-y","pdf_url":"https://www.nature.com/articles/s41416-019-0724-y.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.550000011920929,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1019028848","display_name":"Functional Proteomics by Reverse Phase Protein Array in Cancer","funder_award_id":"R50CA221675","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G10598100","display_name":null,"funder_award_id":"P30CA16672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G132965223","display_name":null,"funder_award_id":"#CA16672","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G1352559466","display_name":null,"funder_award_id":"R01 CA182635","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G1619438925","display_name":null,"funder_award_id":"CA-16672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1727840030","display_name":null,"funder_award_id":"CA-16 672","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3320306848","display_name":"Targeted therapies in cutaneous melanoma","funder_award_id":"R01CA182635","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4984593079","display_name":null,"funder_award_id":"CA182635","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5016707533","display_name":null,"funder_award_id":"P30 CA056036","funder_id":"https://openalex.org/F4320310581","funder_display_name":"Thomas Jefferson University"},{"id":"https://openalex.org/G5406211404","display_name":null,"funder_award_id":"CA160495","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5428753359","display_name":"FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma","funder_award_id":"R01CA160495","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5469383171","display_name":null,"funder_award_id":"R01 CA182635","funder_id":"https://openalex.org/F4320308296","funder_display_name":"Melanoma Research Alliance"},{"id":"https://openalex.org/G640481018","display_name":null,"funder_award_id":"P30CA 16672","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G7066338595","display_name":null,"funder_award_id":"CA056036","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000897668","display_name":"Translational Research in Cancer","funder_award_id":"P30CA056036","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320308296","display_name":"Melanoma Research Alliance","ror":"https://ror.org/025ck6r46"},{"id":"https://openalex.org/F4320308854","display_name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","ror":"https://ror.org/0001ew531"},{"id":"https://openalex.org/F4320310581","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41"},{"id":"https://openalex.org/F4320310773","display_name":"National Cancer Center","ror":"https://ror.org/0065zqt33"},{"id":"https://openalex.org/F4320314643","display_name":"Outrun the Sun","ror":"https://ror.org/0010c9b52"},{"id":"https://openalex.org/F4320330502","display_name":"Plexxikon","ror":"https://ror.org/00qk1xk35"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332521","display_name":"University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3000307305.pdf","grobid_xml":"https://content.openalex.org/works/W3000307305.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W119020121","https://openalex.org/W183067547","https://openalex.org/W1605920927","https://openalex.org/W1969621613","https://openalex.org/W1970195561","https://openalex.org/W1979340580","https://openalex.org/W1991831211","https://openalex.org/W1997087919","https://openalex.org/W2000596495","https://openalex.org/W2011261819","https://openalex.org/W2014445008","https://openalex.org/W2018794234","https://openalex.org/W2019060733","https://openalex.org/W2032099289","https://openalex.org/W2032211985","https://openalex.org/W2041535798","https://openalex.org/W2055624262","https://openalex.org/W2057460011","https://openalex.org/W2058390096","https://openalex.org/W2079076045","https://openalex.org/W2083435672","https://openalex.org/W2112124155","https://openalex.org/W2127258026","https://openalex.org/W2135131549","https://openalex.org/W2136474966","https://openalex.org/W2154748904","https://openalex.org/W2166502164","https://openalex.org/W2168143310","https://openalex.org/W2226721679","https://openalex.org/W2292874918","https://openalex.org/W2299219969","https://openalex.org/W2345014259","https://openalex.org/W2424133004","https://openalex.org/W2476446980","https://openalex.org/W2529244178","https://openalex.org/W2560275756","https://openalex.org/W2569342357","https://openalex.org/W2576619896","https://openalex.org/W2585407512","https://openalex.org/W2619516803","https://openalex.org/W2621002092","https://openalex.org/W2621895366","https://openalex.org/W2738383040","https://openalex.org/W2779503684","https://openalex.org/W2787145482","https://openalex.org/W2797189509","https://openalex.org/W2797477419","https://openalex.org/W2799731732","https://openalex.org/W2803252816","https://openalex.org/W2885459183","https://openalex.org/W2896600825","https://openalex.org/W2904329518"],"related_works":["https://openalex.org/W2115424172","https://openalex.org/W2026352397","https://openalex.org/W2043717258","https://openalex.org/W2977329298","https://openalex.org/W2995691940","https://openalex.org/W2100969832","https://openalex.org/W2947157850","https://openalex.org/W2955071179","https://openalex.org/W2333651255","https://openalex.org/W2080804401"],"abstract_inverted_index":{"BACKGROUND:":[0],"BRAF-mutant":[1,218],"melanoma":[2,32,138,156],"patients":[3],"respond":[4],"to":[5,54,59],"BRAF":[6],"inhibitors":[7,10],"and":[8,84,96,106,124,164,191],"MEK":[9],"(BRAFi/MEKi),":[11],"but":[12,181],"drug-tolerant":[13],"cells":[14],"persist,":[15],"which":[16],"may":[17,208],"seed":[18],"disease":[19],"progression.":[20],"Adaptive":[21],"activation":[22],"of":[23,47,69,122,141,152,205,212],"receptor":[24],"tyrosine":[25],"kinases":[26],"(RTKs)":[27],"has":[28],"been":[29],"associated":[30],"with":[31,117,146,185],"cell":[33],"drug":[34,171],"tolerance":[35],"following":[36,109,132,214],"targeted":[37],"therapy.":[38],"While":[39],"co-targeting":[40],"individual":[41],"RTKs":[42,58],"can":[43],"enhance":[44],"the":[45,74,150,210],"efficacy":[46],"BRAFi/MEKi":[48,120,153,187,215],"effects,":[49],"it":[50],"remains":[51],"unclear":[52],"how":[53],"broadly":[55],"target":[56],"multiple":[57],"achieve":[60],"more":[61],"durable":[62,193],"tumour":[63,194],"growth":[64,88,157],"inhibition.":[65],"METHODS:":[66],"The":[67],"blockage":[68],"adaptive":[70],"RTK":[71],"responses":[72,213],"by":[73,82,93],"new":[75],"BET":[76,206],"inhibitor":[77],"(BETi),":[78],"PLX51107,":[79],"was":[80,89,143,189],"measured":[81],"RPPA":[83],"Western":[85],"blot.":[86],"Melanoma":[87],"evaluated":[90],"in":[91,102,158,160,165,167,175,179,217],"vitro":[92],"colony":[94],"assay":[95],"EdU":[97],"staining,":[98],"as":[99,101],"well":[100],"skin":[103,162],"reconstructs,":[104],"xenografts":[105,166],"PDX":[107],"models":[108],"BRAFi,":[110],"MEKi":[111],"and/or":[112],"PLX51107":[113,118,148],"treatment.":[114],"RESULTS:":[115],"Treatment":[116],"limited":[119],"upregulation":[121],"ErbB3":[123],"PDGFR-\u03b2":[125],"expression":[126,140],"levels.":[127],"Similar":[128],"effects":[129,151],"were":[130],"observed":[131],"BRD2/4":[133,142],"depletion.":[134],"In":[135],"stage":[136],"III":[137],"patients,":[139],"strongly":[144],"correlated":[145],"ErbB3.":[147],"enhanced":[149],"on":[154],"inhibiting":[155],"vitro,":[159],"human":[161],"reconstructs":[163],"vivo.":[168],"Continuous":[169],"triple":[170],"combination":[172],"treatment":[173,188,216],"resulted":[174],"significant":[176],"weight":[177],"loss":[178],"mice,":[180],"intermittent":[182,203],"BETi":[183],"combined":[184],"continuous":[186],"tolerable":[190],"improved":[192],"inhibition":[195,204],"outcomes.":[196],"CONCLUSIONS:":[197],"Together,":[198],"our":[199],"data":[200],"suggest":[201],"that":[202],"proteins":[207],"improve":[209],"duration":[211],"melanoma.":[219]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-01-23T00:00:00"}